中国肛肠病杂志2025，Vol.45Issue(3)：54-56,3.
帕瑞昔布钠联合罗哌卡因用于痔术后镇痛的疗效观察
Clinical Efficacy of Parecoxib Sodium Combined with Ropivacaine for Postoperative Analgesia of Hemorrhoids
摘要
Abstract
Objective To evaluate the clinical efficacy of parecoxib sodium combined with ropivacaine for postoperative hemorrhoidal analgesia.Methods From February 2022 to August 2023,total 70 patients with hemorrhoids who received surgical treatment were randomly divided into the observation group and the control group,with 35 cases in each group.The control group received postoperative analgesia with ropivacaine,and the observation group was given parecoxib sodium combined with ropivacaine for postop-erative analgesia.Postoperative pain,anal edema,clinical indexes and adverse reactions were compared between the two groups.Results The pain scores of the observation group at the 6th,12th,24th 48th and 72th h after surgery were lower than those of the control group(P＜0.05).The anal edge edema scores at the 72h after surgery were lower than those of the control group(P＜0.05).The first urination time and wound healing time were shorter than those of the control group(P＜0.05),and there was no significant difference in the incidence of adverse reactions between the two groups(P＞0.05).Conclu-sion The use of parecoxib sodium combined with ropivacaine for analgesia after hemorrhoid surgery has a significant analgesic effect,can relieve perianal edema and improve clinical indicators,which is safe and worthy of clinical promotion and application.关键词
痔/帕瑞昔布钠/罗哌卡因/术后镇痛Key words
Hemorrhoids/Parecoxib sodium/Ropivacaine/Postoperative analgesia引用本文复制引用
董超科,张春韶,郭晓纯..帕瑞昔布钠联合罗哌卡因用于痔术后镇痛的疗效观察[J].中国肛肠病杂志,2025,45(3):54-56,3.基金项目
2021年龙岗区医疗卫生科技计划项目(非扶持类)(编号LGWJ2021-7) （非扶持类）
